论文部分内容阅读
目的:探讨在老年社区获得性肺炎患者中运用莫西沙星治疗的有效性与安全性。方法:选取2012~2013年本社区收诊的老年社区获得性肺炎患者共64例,并以随机数字表法方式将其分组,每组32例,将其中采取左氧氟沙星静注者纳入对照组,将实施莫西沙星治疗者纳入观察组,分析并评估两组病例的临床疗效及药物安全性。结果:观察组治疗后可取得93.4%的临床总疗效率,要显著性高于对照组的71.9%,有统计学意义(P<0.05);在安全性方面,观察组与对照组的不适症状发生率相仿,无统计学意义(P>0.05)。结论:为老年社区获得性肺炎患者运用莫西沙星治疗有确切疗效,且药物安全性高,值得普及应用。
Objective: To investigate the efficacy and safety of moxifloxacin in elderly patients with community-acquired pneumonia. Methods: A total of 64 senile community-acquired pneumonia patients admitted to our community from 2012 to 2013 were selected and grouped by random number table (32 cases in each group). The patients who took intravenous levofloxacin were included in the control group Moxifloxacin treatment were included in the observation group, analysis and evaluation of two groups of patients with clinical efficacy and drug safety. Results: The total effective rate of treatment in the observation group was 93.4%, which was significantly higher than that in the control group (71.9%, P <0.05). In terms of safety, the symptoms of the observation group and the control group The incidence was similar and not statistically significant (P> 0.05). Conclusion: It is worth to popularize the application of moxifloxacin in senile patients with community-acquired pneumonia and its efficacy is safe and safe.